Facebook Twitter LinkedIn Google Plus RSS

Catalent acquires marketing license for Redwood technology

By ,

Catalent Pharma Solutions, in the Somerset section of Franklin, on Wednesday announced it has acquired an exclusive license to market Redwood Bioscience’s proprietary SmarTag technology for the development of advanced antibody-drug conjugates.

According to an announcement from Catalent, the deal will further improve the company’s capabilities to help customers develop more and better biologic treatments. Terms were not disclosed.

Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy